作者: Anna Astashkina , Brenda Mann , David W. Grainger
DOI: 10.1016/J.PHARMTHERA.2012.01.001
关键词:
摘要: Drug candidate and toxicity screening processes currently rely on results from early-stage in vitro cell-based assays expected to faithfully represent essential aspects of in vivo …